WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.


What’s New in the 2024 CLSI Standards for Antimicrobial Susceptibility Testing?

CLSI On-Demand: 2024 M100 Update Webinar

What’s New in the 2024 CLSI Standards for Antimicrobial Susceptibility Testing?

Recorded on: April 17, 2024

Access this on-demand CLSI webinar discussing the latest in Antimicrobial Susceptibility Testing (AST) guidelines with the release of the 2024 editions of the CLSI M100, M02, and M07 documents. Understand the latest guidance for implementing new breakpoints and standards into your laboratory practices. Some of the major updates discussed during the webinar include:

  • A significant reorganization of dosage recommendations.
  • Addition of sulbactam-durlobactam to breakpoints.
  • A new Table 2A-2 for Salmonella and Shigella.

Moderator:
Janet Hindler, MCLS, MT(ASCP), F(AAM)
Clinical Microbiologist, Los Angeles County Department of Public Health

Speakers:
April Bobenchik, PhD, D(ABMM)
Medical Director Microbiology and Associate Professor, Penn State Health and College of Medicine
Romney Humphries, PhD D(ABMM)
Professor, Department of Pathology, Microbiology and Immunology
Vanderbilt University Medical Center

Watch the webinar on-demand anytime.

Member price:

List Price:
  Webinar  Add to Cart
Log in/sign up to see your price

Details

Date of Webinar: April 17, 2024

CLSI On-Demand: 2024 M100 Update Webinar Additional Details

Learning Objectives:

1. Identify the major changes found in the updated 34th edition of the CLSI M100 document.
2. Design a strategy for implementing the new standard into laboratory practices.
3. Develop a communication strategy for informing clinical staff of significant AST and reporting changes.

CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.